Innate Immunity
Innate Immunity(先天免疫)
Innate Immunity 相关产品(557)
- GC40982Resolvin D5CAS: 578008-43-2纯度: >95.00%
A potent anti-inflammatory, pro-resolving lipid mediator
- GC4110215-deoxy-δ12,14-Prostaglandin D2CAS: 85235-11-6纯度: >95.00%
A metabolite of PGD 2 and an agonist of DP 2
- GC4112312-epi Leukotriene B4CAS: 83709-73-3纯度: >97.00%
LTB 4 isomer with weak agonist activity at BLT 1 and BLT 2 receptors
- GC411275(S),15(S)-DiHETECAS: 82200-87-1纯度: >98.00%
A dihydroxy fatty acid synthesized by 15-LO from 5(S)-HETE
- GC411368(S),15(S)-DiHETECAS: 80234-65-7纯度: >98.00%
A dihydroxy fatty acid synthesized by 15-LO from 15(S)-HETE
- GC4115014,15-Leukotriene E4CAS: 1000852-57-2纯度: >97.00%
A metabolite of 14,15-LTC 4 with pro-inflammatory activity
- GC411601a,1b-dihomo Prostaglandin E2CAS: 26198-80-1纯度: >98.00%
A rare PUFA biosynthesized from adrenic acid
- GC4116415(R)-15-methyl Prostaglandin D2CAS: 210978-26-0纯度: >95.00%
A potent, selective agonist for the CRTH2/DP 2 receptor
- GC41170Prostaglandin D2 methyl esterCAS: 49852-81-5纯度: >97.00%
A more lipid-soluble, cell-permeable prodrug form of PGD 2
- GC4122717(R)-Resolvin D1 methyl esterCAS: 937738-64-2纯度: >95.00%
Methyl ester of an aspirin-triggered resolvin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC40982 | Resolvin D5 | 578008-43-2 | >95.00% | |
A potent anti-inflammatory, pro-resolving lipid mediator | ||||
| GC41096 | 12-oxo Leukotriene B4 | 136696-10-1 | >90.00% | |
A natural metabolite of LTB 4 | ||||
| GC41100 | 14,15-dehydro Leukotriene B4 | 114616-11-4 | >97.00% | |
A LTB 4 receptor antagonist | ||||
| GC41102 | 15-deoxy-δ12,14-Prostaglandin D2 | 85235-11-6 | >95.00% | |
A metabolite of PGD 2 and an agonist of DP 2 | ||||
| GC41107 | Leukotriene B5 | 80445-66-5 | >98.00% | |
A leukotriene | ||||
| GC41123 | 12-epi Leukotriene B4 | 83709-73-3 | >97.00% | |
LTB 4 isomer with weak agonist activity at BLT 1 and BLT 2 receptors | ||||
| GC41126 | 5(S),12(S)-DiHETE | 79056-01-2 | >98.00% | |
A natural bioactive lipid | ||||
| GC41127 | 5(S),15(S)-DiHETE | 82200-87-1 | >98.00% | |
A dihydroxy fatty acid synthesized by 15-LO from 5(S)-HETE | ||||
| GC41136 | 8(S),15(S)-DiHETE | 80234-65-7 | >98.00% | |
A dihydroxy fatty acid synthesized by 15-LO from 15(S)-HETE | ||||
| GC41144 | 11-trans Leukotriene C4 | 74841-69-3 | >97.00% | |
A C-11 double bond isomer of LTC 4 | ||||
| GC41145 | 14,15-Leukotriene C4 | 75290-60-7 | >95.00% | |
A pro-inflammatory arachidonic acid metabolite | ||||
| GC41148 | 14,15-Leukotriene D4 | 75290-64-1 | >97.00% | |
A pro-inflammatory arachidonic acid metabolite | ||||
| GC41150 | 14,15-Leukotriene E4 | 1000852-57-2 | >97.00% | |
A metabolite of 14,15-LTC 4 with pro-inflammatory activity | ||||
| GC41160 | 1a,1b-dihomo Prostaglandin E2 | 26198-80-1 | >98.00% | |
A rare PUFA biosynthesized from adrenic acid | ||||
| GC41164 | 15(R)-15-methyl Prostaglandin D2 | 210978-26-0 | >95.00% | |
A potent, selective agonist for the CRTH2/DP 2 receptor | ||||
| GC41169 | Lipoxin B4 methyl ester | 97589-07-6 | >95.00% | |
A lipid soluble prodrug of LXB 4 | ||||
| GC41170 | Prostaglandin D2 methyl ester | 49852-81-5 | >97.00% | |
A more lipid-soluble, cell-permeable prodrug form of PGD 2 | ||||
| GC41189 | Ricinelaidic Acid | 540-12-5 | >98.00% | |
An LTB 4 antagonist | ||||
| GC41208 | 17(S)-HDHA | 92693-03-3 | >98.00% | |
An oxidation product of DHA | ||||
| GC41222 | Cicaprost | 94079-80-8 | >98.00% | |
Stable analog of prostacyclin | ||||
| GC41227 | 17(R)-Resolvin D1 methyl ester | 937738-64-2 | >95.00% | |
Methyl ester of an aspirin-triggered resolvin | ||||
| GC41231 | Resolvin D2 methyl ester | 810668-53-2 | >95.00% | |
Methyl ester form of RvD2 | ||||
| GC41232 | Resolvin D3 methyl ester | - | >95.00% | |
A methyl ester form of resolvin D3 | ||||
| GC41288 | (±)17(18)-EpETE-Ethanolamide | 2123491-23-4 | >98.00% | |
An ω-3 endocannabinoid epoxide | ||||